Myriad Genetics, Inc.MYGNNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$1.80M
↑ 123% vs avg
Percentile
P36
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-7.87M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.80M | +104.7% |
| 2024 | $-38.40M | +79.2% |
| 2023 | $-184.20M | -21.5% |
| 2022 | $-151.60M | -25366.7% |
| 2021 | $600000.00 | +101.5% |
| 2020 | $-40.10M | -179.4% |
| 2019 | $50.50M | -32.8% |
| 2018 | $75.10M | -30.1% |
| 2017 | $107.50M | +7.4% |
| 2016 | $100.10M | - |